MO RASUL LIMITED

Company number 14216881 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

MO RASUL LIMITED - Analysis Report

Company Number: 14216881

Analysis Date: 2025-07-29 20:57 UTC

Financial Health Assessment Report for MO RASUL LIMITED


1. Financial Health Score: D

Explanation:
MO RASUL LIMITED shows signs of financial stress primarily due to persistent negative working capital over the past three years. Although the company remains solvent with positive net assets, its liquidity position is weak, indicating potential challenges in meeting short-term obligations. The financial stability is fragile but not critical yet. Without corrective action, the risk of cash flow distress may increase.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Fixed Assets 9,285 Stable investment in long-term assets.
Current Assets 19,644 Increased, driven mainly by debtors; cash remains very low.
Cash on Hand 137 Extremely low cash reserves—symptom of liquidity strain.
Debtors 19,507 High amount of receivables, suggesting slow collections.
Current Liabilities 28,781 Rising short-term debts, exceeding current assets.
Net Current Assets -9,137 Negative working capital—potential warning sign of distress.
Net Assets 148 Positive but very low net equity; company has minimal buffer.
Share Capital 4.00 Minimal equity base—typical for micro/small entities.
Profit and Loss Reserve 147 Small retained earnings, reflecting early-stage operations.

3. Diagnosis: Financial Health Overview

  • Liquidity "Pulse" Weakness:
    The company is exhibiting symptoms of liquidity stress with negative net current assets for three consecutive years. This means short-term liabilities consistently exceed short-term assets, which may hinder the company’s ability to pay bills promptly. The very low cash balance compounds this risk, indicating the "cash flow artery" is thin and vulnerable.

  • Receivables "Symptom" Analysis:
    The large debtor balance compared to cash suggests that while the company is generating revenue, it is struggling to convert sales into immediate cash inflows. This slow collection of receivables can exacerbate liquidity problems, much like a patient with poor blood circulation.

  • Solvency Status:
    Despite liquidity issues, the company remains solvent with positive net assets (£148) and shareholders’ funds, though these are minimal. This is a "mild condition" stage where the company is still alive but needs careful management to avoid deterioration.

  • Asset Base and Investment:
    Fixed assets are stable and not declining sharply, indicating no rapid erosion of long-term investment, which is a positive sign. However, the asset base is relatively small, consistent with the company’s micro/small status.

  • Growth and Profitability Indicators:
    The small profit and loss reserve accumulation indicates limited profitability or reinvestment at this early stage. The absence of turnover data limits full assessment, but the financial strain suggests the company is not yet generating strong cash profits.


4. Recommendations: Steps Toward Financial Wellness

  1. Improve Cash Flow Management:
    Prioritize faster collection of receivables. Consider offering early payment discounts or tighten credit terms to reduce debtor days. This will strengthen the "cash flow bloodstream" and relieve liquidity pressure.

  2. Negotiate with Creditors:
    Engage with suppliers and creditors to potentially extend payment terms or restructure short-term liabilities, easing immediate cash demands.

  3. Increase Cash Reserves:
    Explore options to boost cash holdings, such as short-term financing or equity injections. Having a "healthy cash buffer" is critical to withstand unforeseen expenses.

  4. Cost Control and Profitability Focus:
    Review operating expenses and pricing strategies to improve margins and build retained earnings. Enhancing profitability will improve the company’s resilience.

  5. Financial Monitoring:
    Implement regular financial reviews focusing on liquidity ratios (current ratio, quick ratio) and debtor turnover to detect symptoms early and act promptly.

  6. Strategic Growth Planning:
    Ensure that growth in sales is matched by efficient working capital management to avoid exacerbating liquidity issues.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.